Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Maiden Pharmaceuticals

After 66 child deaths, a clean chit, and a ‘vanishing act’: Maiden Pharma is coming back, rebranded

This is the second part of an investigative series examining pharmaceutical companies linked to the deaths of children from contaminated medicines, and the regulatory failures that allowed them to keep operating. It is supported by the Thakur Foundation. The foundation has not exercised any editorial control over the project.

Newslaundry

Indian cough syrup: mystery middleman may be new clue

An unnamed middleman in Mumbai provided a crucial raw material used in Indian-made cough syrups that have been linked to the deaths of more than 70 children in Gambia, a chemicals trader involved in the supply chain told Reuters.

Reuters

Gambia parliament recommends suing of Indian manufacturer of cough syrups

India says premature blame on Indian drugs ‘adversely impacted image’ across globe

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Deaths of Gambian children cast dark shadow over India’s drugs industry

The tragic demise of 66 children in the West African nation of Gambia as a result of the use of suspect cough remedies has brought into focus a dangerous aspect of India’s massive pharmaceutical industry.

Radio France Internationale

Cough syrup deaths: If media doesn’t hold the government to account, who will?

On a day when the biggest news story for most Indian newspapers was India’s almost miraculous win in their match against Pakistan in Melbourne in the ongoing T20 World Cup, one paper decided to make a non-sport and non-political story its page 1 lead.

Newslaundry

Children’s deaths in The Gambia and Indonesia: What to know

Tainted cough syrups pulled from the shelves after they were linked to dozens of deaths.

Al Jazeera

Indonesia bans sale of syrup medicines after at least 99 child deaths

Country investigating 206 cases of kidney injury that could be linked to ingredients in liquid medicines

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Gambia cough syrup-related deaths | CDSCO to examine Maiden Pharma’s role, Haryana sends notice to firm

Haryana Health Minister Anil Vij said that authorities inspected a Maiden Pharmaceuticals factory in Sonepat and found 12 violations of good practices, following which production was ordered stopped

The Hindu

Pharma exporters body suspends membership of Maiden Pharmaceuticals

Pharmexcil had sought details after WHO named the firm in a medical product alert

The Hindu

Syrup shock: India has had own share of drug tragedies

MUMBAI: Some 66 deaths of children in Gambia after consumption of four cough syrups made by the Haryana-based Maiden Pharmaceuticals, the subsequent recall of the drugs by the West African country and a WHO alert have put the spotlight on quality monitoring and due diligence by companies, and the need…

The Times of India

WHO warns against Indian-made cough remedies as 66 children die in Gambia

The World Health Organization has issued a warning that four cough and cold syrups produced by Maiden Pharmaceuticals in India could be linked to the deaths of 66 children in Gambia. The UN health agency says contaminated medication may have been distributed to other countries.

Radio France Internationale

Cough syrup warning after 66 children die in The Gambia

WHO says medications in question may have been distributed outside The Gambia

The Independent UK

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

United Nations

37,273 stories

Bharatiya Janata Party

World Health Organization

World Health Organisation

Maiden Pharmaceuticals

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.